Osteoarthritis, Hip

2
Pipeline Programs
5
Companies
8
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
2
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

5 companies ranked by most advanced pipeline stage

J&
Johnson & JohnsonNEW BRUNSWICK, NJ
2 programs
2
Articular Surface ReplacementPhase 31 trial
Oxycodone CRPhase 31 trial
Active Trials
NCT00391937Completed150Est. Jan 2013
NCT00361504Completed1,123Est. Jul 2008
Anika Therapeutics
Anika TherapeuticsMA - Bedford
2 programs
CingalN/A1 trial
MonoviscN/A1 trial
Active Trials
NCT04640298CompletedEst. Sep 2021
NCT04204083CompletedEst. Mar 2021
C
CorinUK - Cirencester
2 programs
Corin Optimised Positioning SystemN/A1 trial
MetaFix Collared StemN/A1 trial
Active Trials
NCT03560063UnknownEst. May 2022
NCT05121636Active Not RecruitingEst. Sep 2027
Medacta
MedactaSwitzerland - Castel San Pietro
1 program
Femoral Component:Medacta Masterloc Stem and Medacta MPACT cup.N/A1 trial
Active Trials
NCT03168750CompletedEst. Nov 2024
Organogenesis
OrganogenesisCANTON, MA
1 program
ReNu™ InjectionN/A1 trial
Active Trials
NCT03063099CompletedEst. Jun 2019

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
Johnson & JohnsonOxycodone CR
Johnson & JohnsonArticular Surface Replacement
Anika TherapeuticsCingal
Anika TherapeuticsMonovisc
CorinCorin Optimised Positioning System
MedactaFemoral Component:Medacta Masterloc Stem and Medacta MPACT cup.
OrganogenesisReNu™ Injection
CorinMetaFix Collared Stem

Clinical Trials (8)

Total enrollment: 1,273 patients across 8 trials

NCT00361504Johnson & JohnsonOxycodone CR

A Study to Evaluate Long-Term Safety of Multiple Doses of Tapentadol (CG5503) Prolonged-Release (PR) and Oxycodone Controlled-Release (CR) in Patients With Chronic Pain

Start: Nov 2006Est. completion: Jul 20081,123 patients
Phase 3Completed
NCT00391937Johnson & JohnsonArticular Surface Replacement

Efficacy of a New Resurfacing Hip Prosthesis

Start: Oct 2006Est. completion: Jan 2013150 patients
Phase 3Completed
NCT04640298Anika TherapeuticsCingal

Study of Cingal® for Symptomatic Relief of Osteoarthritis of Hip Joint

Start: Jan 2021Est. completion: Sep 2021
N/ACompleted
NCT04204083Anika TherapeuticsMonovisc

MONOVISC for Hip Joint Pain Relief Due to Osteoarthritis

Start: Dec 2019Est. completion: Mar 2021
N/ACompleted
NCT03560063CorinCorin Optimised Positioning System

The Hip Arthroplasty Positioning Improvement Study

Start: May 2018Est. completion: May 2022
N/AUnknown
NCT03168750MedactaFemoral Component:Medacta Masterloc Stem and Medacta MPACT cup.

Analysis of a Tapered Porous Coated Stem and a Cementless Hemispherical Acetabular Component

Start: Jul 2017Est. completion: Nov 2024
N/ACompleted
NCT03063099OrganogenesisReNu™ Injection

ReNu™ Injection to Treat Hip Osteoarthritis Study

Start: Feb 2017Est. completion: Jun 2019
N/ACompleted
NCT05121636CorinMetaFix Collared Stem

Clinical Outcomes Following Total Joint Replacement With Corin Prostheses: Corin MetaFix Collared Stem

Start: Jun 2016Est. completion: Sep 2027
N/AActive Not Recruiting

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

2 late-stage (Phase 3) programs — potential near-term approvals
5 companies competing in this space